Honz Pharmaceutical Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Honz Pharmaceutical Co Ltd with three other
companies in this sector in China:
Sinovac Biotech Ltd
sales of 481.91 million Chinese Renmimbi [US$74.60 million]
of which 49%
was Enterovirus 71 vaccines),
Lionco Pharmaceutical Group Co Ltd
(478.59 million Chinese Renmimbi [US$74.09 million]
of which 100%
was Medicine), and
Tibet AIM Pharm Inc
(451.92 million Chinese Renmimbi [US$69.96 million]
of which 62%
During the year ended December of 2016, sales at
Honz Pharmaceutical Co Ltd were 471.46 million Chinese Renmimbi (US$72.98 million).
increase of 15.1%
versus 2015, when the company's sales were 409.59 million Chinese Renmimbi.
This was the third consecutive year of growth at Honz Pharmaceutical Co Ltd.